[go: up one dir, main page]

TR201917675A2 - Bi̇r yara bakim ürünü - Google Patents

Bi̇r yara bakim ürünü Download PDF

Info

Publication number
TR201917675A2
TR201917675A2 TR2019/17675A TR201917675A TR201917675A2 TR 201917675 A2 TR201917675 A2 TR 201917675A2 TR 2019/17675 A TR2019/17675 A TR 2019/17675A TR 201917675 A TR201917675 A TR 201917675A TR 201917675 A2 TR201917675 A2 TR 201917675A2
Authority
TR
Turkey
Prior art keywords
care product
wound care
boric acid
wound
healing
Prior art date
Application number
TR2019/17675A
Other languages
English (en)
Inventor
Kapukaya Rana
Murat Özayman Nuri̇
Original Assignee
Ulusal Bor Arastirma Enstituesue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulusal Bor Arastirma Enstituesue filed Critical Ulusal Bor Arastirma Enstituesue
Priority to TR2019/17675A priority Critical patent/TR201917675A2/tr
Priority to PCT/TR2020/051083 priority patent/WO2021096469A1/en
Publication of TR201917675A2 publication Critical patent/TR201917675A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, antibakteriyel bileşenleri olarak nano borik asit partikülleri ve asidik ortamda daha verimli olan antibiyotikler taşıyan, tamamlayıcı etkileri için ek bileşenler içeren bir yara bakım ürünü ile ilgilidir. Buluşun amacı, antibakteriyel bileşen olarak, teknikte sıklıkla kullanılan ancak zararlı yan etkilere sahip olan gümüş nitrat partikülleri yerine daha biyouyumlu olan borik asit nano partiküllerinin kullanıldığı, etkili salınım süresinin uzatıldığı, böylece hücre ve akyuvar proliferasyonunun indüklenmesini arttıran, yara izi bırakmadan yara iyileştirilmesini sağlayan ve yara iyileştirme sürecini hızlandıran bir yara bakım ürünü geliştirilmesidir.
TR2019/17675A 2019-11-13 2019-11-13 Bi̇r yara bakim ürünü TR201917675A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/17675A TR201917675A2 (tr) 2019-11-13 2019-11-13 Bi̇r yara bakim ürünü
PCT/TR2020/051083 WO2021096469A1 (en) 2019-11-13 2020-11-11 A wound care product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/17675A TR201917675A2 (tr) 2019-11-13 2019-11-13 Bi̇r yara bakim ürünü

Publications (1)

Publication Number Publication Date
TR201917675A2 true TR201917675A2 (tr) 2021-05-21

Family

ID=75912268

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/17675A TR201917675A2 (tr) 2019-11-13 2019-11-13 Bi̇r yara bakim ürünü

Country Status (2)

Country Link
TR (1) TR201917675A2 (tr)
WO (1) WO2021096469A1 (tr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003062443A2 (en) * 2001-11-08 2003-07-31 Antex Pharma, Inc. Novel substituted alkane compounds and uses thereof
WO2008043175A1 (en) * 2006-10-13 2008-04-17 Kane Biotech Inc. SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF
CA2738245A1 (en) * 2008-09-26 2010-04-01 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
CN102695528B (zh) * 2009-08-21 2016-07-13 诺万公司 创伤敷料、其使用方法及其形成方法
WO2014165253A1 (en) * 2013-03-12 2014-10-09 Nbip, Llc Compositions and methods for preventing infection of a wound and for advancing the healing process

Also Published As

Publication number Publication date
WO2021096469A1 (en) 2021-05-20

Similar Documents

Publication Publication Date Title
CY1121663T1 (el) Μιγμα rp/sp gemcitαβινε- [ρηενyl-(benzyloxy-l-alανιnyl)]-phosphate
CY1122186T1 (el) Μεθοδοι θεραπειας καρκινου
MX386598B (es) Compuestos antibacterianos.
MX2016009898A (es) Tratamientos para acne resistente.
SA517381998B1 (ar) تركيبة لتضميد الجرح
MX2018003594A (es) Anticuerpo anti-garp.
EP4289910A3 (en) Methods and compositions for wound healing
CL2015002445A1 (es) Compuestos amida para el tratamiento del vih
EP4414030A3 (en) Treatment of fragile x syndrome with cannabidiol
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
BRPI0917552B8 (pt) kit para o tratamento de onicomicose
EA201590709A1 (ru) Комбинированная терапия и ее применение для лечения димиелинизирующих расстройств
NI201300101A (es) Modulación de la expresión del transductor de señales y activador de la transcripción 3 (stat3)
MX382832B (es) Benzimidazoles sustituidos, su preparación y su uso como productos farmacéuticos.
MX386565B (es) Pirimidopirimidinonas útiles como inhibidores de la quinasa wee-1.
MX2022010466A (es) Tratamiento conjunto contra tipos de cancer hematologico.
MX369609B (es) Una composición para usarse en el tratamiento de cáncer deficiente en nmt2.
TR201903940T4 (tr) Uzatılmış salımlı etken madde içeren pansuman.
EA032501B9 (ru) Способы и композиции для содействия заживлению острой раны и хронической раны
MX2018006953A (es) Compuestos de platino funcionalizados con monomaleimida para la terapia del cancer.
GB2524707A (en) Small molecules that promote skin regeneration
MX363604B (es) Composición que comprende una combinación de un polímero acrílico y un copolímero de silicona y un aminoácido o un derivado de aminoácido.
EP4512816A3 (en) Tlr7 agonists
TR201917675A2 (tr) Bi̇r yara bakim ürünü
TR201819270T4 (tr) Glikozaminoglikanlar Ve Siklodekstrinlerin Kombinasyonu